FCGR3A and plasma cell myeloma: In a similar fashion, we observed CD38KO/CD16-158V-transfected NK cells had superior DARA-mediated myeloma killing compared with CD38WT/CD16-158V-transfected and CD38KO NK cells from low-affinity CD16-158F/F homozygous donors.